Collagen-induced human platelet stimulation is dependent on moderately decreased when TxA2 synthesis or TxA2 receptors the release of arachidonic acid (AA) from membrane were blocked by BW755C or GR32191B respectively. The phospholipid and the formation of thromboxane A2 (TxA2) 
INTRODUCTION
membrane signalling [6, 19] . The release of AA via phospholipase A2 is accompanied by the liberation of the corresponding l-acylPlatelet stimulation by agonists such as collagen, thrombin or the 2-lyso-phospholipids [20] . At lower collagen levels, it has been calcium ionophore A23187 leads to the release of arachidonic possible to monitor the individual ['4C]stearoyl-labelled l-acyl-2-acid (AA; C20:4,n-6) from membrane phospholipids [1] [2] [3] [4] [5] [6] . The lyso-phospholipids generated via phospholipase A2 activation stimulated release of AA upon receptor occupancy, via under conditions where no marked decrease in the corresponding phospholipase A2, and the subsequent metabolism ofAA through parent phospholipids was readily observed [21] . Such studies the cyclooxygenase and thromboxane synthetase generates the indicate that the diacylphospholipids, namely phosphatidylpotent pro-aggregatory metabolite thromboxane A2 (TxA2).
choline, phosphatidylethanolamine, phosphatidylserine and Recent studies in human platelets have focused on AA turnover phosphatidylinositol, can be degraded by a combination of within the individual phospholipids [2, 4, 5, [7] [8] [9] [10] [11] . Much of the eicosanoid-independent and -dependent processes, the TxA2-research in this area has employed high levels of thrombin as an dependent pathway being particularly active on phosphatidylagonist which permits the monitoring of radioactivity loss from choline.
the various phospholipids after pre-labelling with AA. The latter It has been determined that [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] % of the ethanolaminestudies have indicated that phosphatidylcholine [1, 2, 4, 5, 7, [9] [10] [11] phospholipid in human platelets is represented by plasmenyland phosphatidylethanolamine [5, 9] are major sources of ethanolamine [22] [23] [24] . Since 68-72o% of the fatty acids residing phospholipase A2-mediated AA release, whereas some AA can in the sn-2 position of the plasmenylethanolamine is represented also be freed by diacylglycerol/monoacylglycerol lipase activities by AA [22, 25] , this specific phospholipid is a significant conafter phospholipase C action on phosphoinositides [12, 13] . The tributor to the total AA-containing phospholipid in human possible role of plasmenylethanolamine (1-O-alk-l'-enyl-2-acylplatelets. It can be calculated that plasmenylethanolamine sn-glycero-3-phosphoethanolamine) as a source of AA for TxA2 represents 300% of the total reservoir of AA-containing synthesis has also been suggested [2, 7, 10, 11] .
phospholipid in resting human platelets, whereas the phosphaCollagen-induced platelet aggregation is dependent on the tidylcholine and phosphatidylethanolamine account for 21 % early release of AA and its subsequent conversion into TxA2 and 160% respectively [22, 26] . [14] [15] [16] [17] [18] , especially at lower levels of collagen [16, 18] methanol/0.9 % KCI (10:9, by vol.), and lipids from the initial methanol/0.9 % KCI upper phase were re-extracted with 2.5 ml of chloroform. The chloroform phases were pooled, dried under nitrogen at 40°C, and resuspended in 25 ,l of chloroform/methanol (2:1, by vol.). Phospholipids were separated by two-dimensional t.l.c. by a modification of the method of Horrocks [31] . Phospholipid samples, to which 40,ug of unlabelled lysophosphatidylethanolamine standard was added, were spotted in the lower right-hand corner of silica-gel 60 plates, previously activated for 30 min at 80 'C. The plates were developed for 90 min in a paper-lined chromatographic tank, which was pre-equilibrated for 45 (130:70:11, by vol.). This first development yielded a mixed fraction containing phosphatidylethanolamine plus plasmenylethanolamine and another containing lysophosphatidylethanolamine plus lysoplasmenylethanolamine (resulting from phospholipase A2 cleavage of plasmenylethanolamine in stimulated platelets). Between dimensions, the plates were removed, dried for 10 min at ambient temperature and then dried in an oven at 40 'C for 30 min. A 4 cm band of the silica-gel plate, containing the mixed parent and mixed lyso forms of ethanolamine-containing phospholipid, was exposed for 3 min to conc. HCI fumes by facing the plate over a Pyrex oven dish (23 cm x 14 cm) containing 100 ml of HCI. The plates were dried again at 40 'C for 15 min, before being developed from the right edge for 2 h in the second solvent system containing chloroform/methanol/88 % formic acid/water (55:28:5: 1, by vol.). Individual phospholipids were observed under u.v. light after spraying with O.10.0% ANS solution in water [32] . The areas containing phosphatidylethanolamine, lyso(2-acyl)phosphatidylethanolamine (generated by HCl-fume exposure from plasmenylethanolamine), lysophosphatidylethanolamine, as well as GPE (generated by HCI fumes from lysoplasmenylethanolamine) were scraped into scintillation-counting vials. Both ethanolamine-containing lysophospholipids co-migrate during the first t.l.c. development; although not detected by ANS, GPE, which does not migrate during the second t.l.c. development, resides at the origin. Distilled water (1.5 ml) was added to the vials before addition of 16 ml of CytoScint, and the samples were counted for radioactivity in a liquid-scintillation counter. The measured radioactwiity in the GPE fraction derived from stimulated minus control platelets represents the [3H]lysoplasmenylethanolamine resulting from phospholipase A2 (agonist-induced) cleavage.
TxA2 measurement
Samples (1 ml) of platelet suspensions were stimulated with collagen in the absence and presence of BW755C as described.
The reactions were stopped by addition of 25 /,tM indomethacin, and the cuvettes were transferred on to ice. Platelet samples were centrifuged at 3000 g for 15 min at 4°C, and the supernatants were removed and stored at -80 'C. Thromboxane B2, the stable metabolite of TxA2, was determined in duplicate by radioimmunoassay [33] .
Mass determination of AA in ethanolamine-containing phospholipids
The AA content of the plasmenylethanolamine and phosphatidylethanolamine of resting and collagen-stimulated platelets (2 ,tg/5 x 108 platelets; 10 min) was determined by procedures similar to those previously described [25, 34] . For this purpose, after t.l.c. as described above, the fatty-acid methyl esters derived from the lyso(2-acyl)phosphatidylethanolamine, representing the 2-position of the parent plasmenylethanolamine, and from the phosphatidylethanolamine were analysed by g.l.c. in the presence of a known amount of pentadecanoate as an internal standard [25, 34] .
Statistical analysis
The data were log-transformed and analysed by analysis of variance (ANOVA). The log-transformation was not performed when ratios were to be analysed. Specific differences for preplanned comparisons between treatment means were examined by Student's t test. The data of AA mass from ethanolaminecontaining phospholipids were analysed by paired t test [35] .
RESULTS
To determine the optimal time of HCl-fume exposure for complete hydrolysis of the alkenyl linkage in the plasmalogenic phospholipids (without detectable cleavage of the acyl forms), preliminary experiments were performed with a standard mixture of plasmenylethanolamine and diacylphosphatidylethanolamine from bovine brain. Maximum hydrolysis of plasmenylethanolamine occurred after 2.5 min, whereas phosphatidylethanolamine remained stable for at least 5 min upon HCl-fume treatment (results not shown). From these experiments, HCl-fume exposure was routinely set at 3 min. El Tamer et al. [36] reported some acyl-bond hydrolysis by t-his treatment as compared with phospholipase A1 digestion. However, the acyl-bond hydrolysis observed in their study may be the result of a longer HCl-fume treatment (10 min).
Measurements of TxA2 in resting and, stimulated platelets exposed to collagen for 2 min gave levels of 2.8 and 69.4 ng/5 x 108 platelets respectively, in the absence of BW755C. It was observed that more than 9500 of the agonist-induced formation of TxA2 was blocked by preincubation with 100 ,uM BW755C.
The -time-dependent generation of [3H]lysoplasmenylethanolamine, via phospholipase A2 action on [3H]plasmenylethanolamine, in collagen-stimulated platelets as studied in the absence and presence of BW755C is presented in Figure 1 The combined data in Similar results to those observed with BW755C were obtained in collagen-stimulated platelets using the TxA2-receptor antagonist GR32191B (Table 3) . A 32500 and 234°rise in
[3H]lysoplasmenylethanolamine, and a 200 and 159°/o rise in [3H]lysophosphatidylethanolamine, above control values was observed in the presence or absence of GR32191B respectively. A moderate increase of 42 , and 50°' above control values for corresponding lysophospholipids occurred in platelets stimulated with U46619, whereas this was blocked by the presence of GR32191B.
To demonstrate that AA was lost from the ethanolaminecontaining phospholipids upon low-level collagen exposure, mass determinations were performed ( Table 4) . The results indicated a significant (P < 0.05) net loss of AA from the plasmenylethanolamine (by 0.74 + 0.19 nmol/5 x 108 platelets) and the phosphatidylethanolamine (by 0.74+0.17 nmol/5 x 108 platelets) due to agonist stimulation.
DISCUSSION
As pointed out by Kambayashi et al. [11] , limited information is available on the stimulus-linked metabolism of plasmenylethanolamine in platelets, owing to the relatively poor labelling of this ether phospholipid with radioactive AA, and the need to resolve the 1-alkenyl from the corresponding 1-acyl sub-class of ethanolaminephospholipid. Such labelling studies have demonstrated a marked rise in radioactive AA appearing in plasmenylethanolamine with the use of thrombin [2, 4, 5, 7, 9] , a strong agonist, but do not provide direct evidence of plasmenylethanolamine breakdown via phospholipase A2. The latter findings have provided evidence for the transacylation pathway which mediates the transfer of AA from phosphatidylcholine to plasmenylethanolamine [10] . A corresponding decrease in the mass of plasmenylethanolamine has been reported [37] in human platelets exposed to thrombin, as has the accumulation of lysoplasmenylethanolamine in human [3] and rabbit [38] platelets. With low levels of collagen as an agonist (i.e. 2 ,ug/ml of platelet suspension), extreme difficulty in detecting any measurable loss of individual labelled/unlabelled phospholipids has been indicated. The present experimental approach, which employed pre-labelling of the plasmenylethanolamine (and phosphatidylethanolamine) in intact human platelets with [3H]ethanolamine, provided the opportunity to monitor the lysoplasmenylethanolamine generated via phospholipase A2 activity using low levels of collagen (with or without BW755C) and the TxA2 mimetic (U46619) as agonists. Free [3H]ethanolamine can potentially enter ethanolamine phospholipid through a combination of base exchange [39] and biosynthetic reactions de novo [40, 41] .
As reviewed by Arita et al. [42] , collagen addition to platelets elicits various biochemical responses in addition to platelet aggregation, including inositol phosphate formation, intracellular Ca2+ mobilization, AA release and TxA2 generation. Collageninduced platelet responses can be distinguished by TxA2-independent and -dependent events, with the initial TxA2-independent process involving activation of phospholipase A2, leading to AA release and TxA2 synthesis. The TxA2 generated in turn activates phospholipase A2 via transmembrane signalling processes for further AA release. The present findings indicate that collagen stimulation of human platelets activates the phospholipase A2-mediated generation of lysoplasmenylethanolamine from plasmenylethanolamine in an eicosanoid-independent manner ( Figure 1 and Table 1 ). We observed that 720 of the generated lysoplasmenylethanolamine was maintained when eicosanoid synthesis was inhibited by the dual cyclo-oxygenase/lipoxygenase inhibitor, BW755C ( Table 1 ). The moderate diminution in agonist-induced lysoplasmenylethanolamine accumulation observed upon BW755C addition (by 28 %) and the ability of U46619 to promote moderately (by 29 0%) its generation (Table   1) indicate some hydrolysis of plasmenylethanolamine via an eicosanoid/TxA2-mediated mechanism. As observed with BW755C, the presence of 1 ,uM GR32191B, the TxA2-receptor antagonist, also had only a moderate inhibitory effect on the generation of lysoplasmenylethanolamine in collagen-stimulated platelets (Table 3 ). This suggests that the eicosanoid-dependent breakdown of these phospholipids is mainly due to TxA2, the potent pro-aggregatory metabolite of AA. The corresponding data on the agonist-induced generation of labelled lysophosphatidylethanolamine ( Figure 2 and Table 1 ) are in agreement with previous work demonstrating the involvement of both eicosanoid-independent and -dependent mechanisms for the cleavage of phosphatidylethanolamine by phospholipase A2 in collagen-stimulated human platelets [21] . In contrast with the finding on ethanolamine phospholipids, the activated phospholipase A2-mediated hydrolysis of phosphatidylcholine to 1-acyl (2-lyso) derivative upon platelet stimulation with low levels of collagen (under the same conditions used herein) was found to be highly sensitive to inhibition by BW755C, indicating little eicosanoid-independent hydrolysis [21] .
The radioactivity ratios (lysophosphatidylethanolamine/ lysoplasmenylethanolamine) in the accumulated lyosphospholipids (agonist-induced) upon collagen stimulation (+ BW755C), which were smaller than the corresponding parent phospholipids (1.2 versus 2.3; Table 2 ), suggests some preferential hydrolysis of the plasmenylethanolamine via the eicosanoid-independent process. Conversely, the somewhat higher ratio in the lysophospholipids relative to the parent phospholipids (3.3 versus 2.3) with U46619 as agonist (Table 2) suggests a moderate preference for phosphatidylethanolamine hydrolysis via the eicosanoid/TxA2-dependent pathway. However, a firm conclusion is difficult in this regard, since these lysophospholipids are subject to some hydrolysis by lysoplasmalogenase/ lysophospholipase activities as well as acylation/transacylation reactions [10, 43] . Studies in vitro in disrupted resting platelets have demonstrated the presence of a phospholipase A2 which can cleave plasmenylethanolamine [44] . Although the ethanolaminecontaining phospholipid was not specifically studied, a plasmalogen-selective phospholipase A2 (Ca2+-independent) has been identified [45] and recently purified [46] from dog myocardium, which acts on plasmenylcholine. A Ca2+-dependent phospholipase A2 which hydrolyses plasmenylcholine has been identified and purified from sheep platelets [47] . The mass measurements (Table 4) showing a significant loss of AA from plasmenylethanolamine support a simultaneous release of AA and lysoplasmenylethanolamine generation via enhanced phospholipase A2 activity in collagen-stimulated human platelets.
The relationship of phospholipase A2-mediated hydrolysis of plasmenylethanolamine as studied herein upon collagen stimulation to platelet aggregation, phosphoinositide turnover, Ca2+ mobilization and protein kinase activation remains to be studied. Interestingly, Moriyama et al. [48] have concluded that TxA2 directly causes Ca2+ mobilization without further activation of phospholipase C upon collagen addition to human platelets. It is possible that the eicosanoid-independent release of AA from plasmenylethanolamine is particularly important in this regard. Also of interest is the similarity of the time course of generation of [3H]ethanolamine-containing lysophospholipids in collagenstimulated platelets (Figures 1 and 2) with that of the timedependent formation of TxB2 reported by Karniguian et al. [49] .
In conclusion, the present study indicates that plasmenylethanolamine, which represents the single predominant reservoir of AA-containing phospholipid in resting human platelets, is hydrolysed in collagen-stimulated platelets to a considerable extent via eicosanoid/TxA2-independent as well as eicosanoid/ TxA2-dependent mechanisms. The eicosanoid-independent hydrolysis of plasmenylethanolamine by phospholipase A2 may represent an important source of releasable AA for the initial TxA2 synthesis and TxA2-induced hydrolysis of other phospholipids via phospholipase A2 (for further AA release) and phospholipid-mediated signalling processes.
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